Endogenous cardiotonic steroids in chronic renal failure | Zendy

Е. В. Колмакова | Zendy; Steven T. Haller | Zendy; Daniel Kennedy | Zendy; Алина Исачкина | Zendy; G. V. Budny | Zendy; Е. В. Фролова | Zendy; Grzegorz Piecha | Zendy; Е. Р. Никитина | Zendy; Deepak Malhotra | Zendy; О. В. Федорова | Zendy; Jamie Shapiro | Zendy; Alexei Y. Bagrov | Zendy

AI Assistant Blog Pricing

Open Access

Endogenous cardiotonic steroids in chronic renal failure

Author(s) -

Е. В. Колмакова,

Steven T. Haller,

Daniel Kennedy,

Алина Исачкина,

G. V. Budny,

Е. В. Фролова,

Grzegorz Piecha,

Е. Р. Никитина,

Deepak Malhotra,

О. В. Федорова,

Jamie Shapiro,

Alexei Y. Bagrov

Publication year - 2011

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfq772

Subject(s) - medicine , pathogenesis , kidney disease , endogeny , chronic renal failure , digitalis , endocrinology , kidney , disease , heart failure

Previous reports demonstrated that digitalis-like cardiotonic steroids (CTS) contribute to the pathogenesis of end-stage renal disease. The goal of the present study was to define the nature of CTS in patients with chronic kidney disease (CKD) and in partially nephrectomized (PNx) rats.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog